The cost-effectiveness of multi- purpose HIV and pregnancy prevention technologies in South Africa

被引：0
|
作者：
Quaife, M. [1 ,2 ]
Terris-Prestholt, F. [1 ]
Eakle, R. [2 ]
Escobar, M. A. Cabrera [2 ]
Kilbourne-Brook, M. [3 ]
Mvundura, M. [3 ]
Meyer-Rath, G. [4 ,5 ]
Delany-Moretlwe, S. [2 ]
Vickerman, P. [6 ]
机构：
[1] London Sch Hyg & Trop Med, Global Hlth & Dev, London, England
[2] Univ Witwatersrand, Wits RHI, Johannesburg, South Africa
[3] PATH, Seattle, WA USA
[4] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA
[5] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa
[6] Univ Bristol, Bristol, Avon, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
WEAE0405
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [1] The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa
    Quaife, Matthew
    Terris-Prestholt, Fern
    Eakle, Robyn
    Escobar, Maria A. Cabrera
    Kilbourne-Brook, Maggie
    Mvundura, Mercy
    Meyer-Rath, Gesine
    Delany-Moretlwe, Sinead
    Vickerman, Peter
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 (03)
  • [2] Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa
    Glaubius, Robert L.
    Hood, Greg
    Penrose, Kerri J.
    Parikh, Urvi M.
    Mellors, John W.
    Bendavid, Eran
    Abbas, Ume L.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (04) : 539 - 547
  • [3] Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
    Sabina S Alistar
    Philip M Grant
    Eran Bendavid
    BMC Medicine, 12
  • [4] Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
    Alistar, Sabina S.
    Grant, Philip M.
    Bendavid, Eran
    BMC MEDICINE, 2014, 12
  • [5] Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050
    Granich, Reuben
    Kahn, James G.
    Bennett, Rod
    Holmes, Charles B.
    Garg, Navneet
    Serenata, Celicia
    Sabin, Miriam Lewis
    Makhlouf-Obermeyer, Carla
    Mack, Christina De Filippo
    Williams, Phoebe
    Jones, Louisa
    Smyth, Caoimhe
    Kutch, Kerry A.
    Lo Ying-Ru
    Vitoria, Marco
    Souteyrand, Yves
    Crowley, Siobhan
    Korenromp, Eline L.
    Williams, Brian G.
    PLOS ONE, 2012, 7 (02):
  • [6] The Case for Adolescent HIV Vaccination in South Africa A Cost-Effectiveness Analysis
    Moodley, Nishila
    Gray, Glenda
    Bertram, Melanie
    MEDICINE, 2016, 95 (04)
  • [7] Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis
    Haacker, Markus
    Fraser-Hurt, Nicole
    Gorgens, Marelize
    PLOS MEDICINE, 2016, 13 (05):
  • [8] Portfolios of Biomedical HIV Interventions in South Africa: A Cost-Effectiveness Analysis
    Elisa F. Long
    Robert R. Stavert
    Journal of General Internal Medicine, 2013, 28 : 1294 - 1301
  • [9] Portfolios of Biomedical HIV Interventions in South Africa: A Cost-Effectiveness Analysis
    Long, Elisa F.
    Stavert, Robert R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (10) : 1294 - 1301
  • [10] Modeling and Cost-Effectiveness in HIV Prevention
    Margo M. Jacobsen
    Rochelle P. Walensky
    Current HIV/AIDS Reports, 2016, 13 : 64 - 75
12345